Fny Investment Advisers, LLC Edesa Biotech, Inc. Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 10, 2022	SELL	$5.17 - $8.65 $8,478 - $14,186	-1,640 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$4.2 - $11.92 $6,888 - $19,548	1,640 New	1,640 $12,000
Q1 2021 Apr 12, 2021	SELL	$4.3 - $7.48 $322,500 - $561,000	-75,000 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$4.25 - $8.14 $192,979 - $369,612	-45,407 Reduced 37.71%	75,000 $318,000
Q3 2020 Oct 09, 2020	BUY	$4.65 - $9.45 $559,892 - $1.14 Million	120,407 New	120,407 $971,000

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $38.2M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.